FDA Inspection 1157916 — University Of Alabama Hospital Blood Bank
The FDA completed an inspection of University Of Alabama Hospital Blood Bank on Nov 17, 2021 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 17, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Birmingham, AL (United States)